Bordetella petrii DSM 12804

Names Bordetella petrii DSM 12804
Accession numbers NC_010170
Background The genus Bordetella comprises one environmental isolate and several human and animal pathogens. Bordetella petrii (strain ATCC BAA-461 / DSM 12804 / CCUG 43448), the only facultatively anerobic Bordetella, was isolated from an anaerobic, dechlorinating bioreactor culture enriched from river sediment in Germany. It was isolated from the dechlorinating mixed culture due to its ability to anaerobically reduce selenate to elemental selenium. B.petrii strains have also been isolated from cystic fibrosis patients, from patients with degenerative bone disease as well as from marine sponges and a grass root consortium. Compared to other Bordetellae, B.petrii DSM 12804 has many mobile genetic elements (22% of its genome) including 7 laterally acquired genomic islands. All of these genomic island are still mobile within the DSM 12804 population. It has the ability to degrade a remarkable variety of aromatic compounds, which explains the large variety of niches from which it has been isolated. It encodes various virulence factors, but lacks all known toxins found in pathogenic Bordetella (adapted from PubMed 18826580). (HAMAP: BORPD)
Strain DSM 12804
Complete Yes
Sequencing centre (21-DEC-2007) National Center for Biotechnology Information, NIH, Bethesda, MD 20894, USA
(26-OCT-2007) Linke B., Center For Biotechnology, Bielefeld University, Universitaetsstrasse 25, 33501 Bielefeld,
Sequencing quality Level 6: Finished
Sequencing depth NA
Sequencing method NA
Isolation site Anaerobic dechlorinating bioreactor culture enriched from river sediment
Isolation country NA
Number of replicons 1
Gram staining properties Negative
Shape NA
Mobility No
Flagellar presence Yes
Number of membranes 2
Oxygen requirements Anaerobic
Optimal temperature NA
Temperature range Mesophilic
Habitat Aquatic
Biotic relationship Free living
Host name NA
Cell arrangement NA
Sporulation NA
Metabolism Selenate reducer
Selenate reducer
Energy source Heterotroph
Diseases NA
Pathogenicity NA
Glycolysis / Gluconeogenesis
Citrate cycle (TCA cycle)
Pentose phosphate pathway
Fatty acid biosynthesis
Fatty acid metabolism
Synthesis and degradation of ketone bodies
Ubiquinone and other terpenoid-quinone biosynthesis
Purine metabolism
Pyrimidine metabolism
Alanine, aspartate and glutamate metabolism
Glycine, serine and threonine metabolism
Cysteine and methionine metabolism
Valine, leucine and isoleucine degradation
Geraniol degradation
Valine, leucine and isoleucine biosynthesis
Lysine biosynthesis
Arginine and proline metabolism
Histidine metabolism
Phenylalanine metabolism
Chlorocyclohexane and chlorobenzene degradation
Benzoate degradation
Fluorobenzoate degradation
Tryptophan metabolism
Phenylalanine, tyrosine and tryptophan biosynthesis
Selenocompound metabolism
Cyanoamino acid metabolism
D-Glutamine and D-glutamate metabolism
D-Arginine and D-ornithine metabolism
D-Alanine metabolism
Glutathione metabolism
Lipopolysaccharide biosynthesis
Peptidoglycan biosynthesis
Pyruvate metabolism
Toluene degradation
Glyoxylate and dicarboxylate metabolism
Propanoate metabolism
Ethylbenzene degradation
Styrene degradation
Butanoate metabolism
C5-Branched dibasic acid metabolism
One carbon pool by folate
Thiamine metabolism
Riboflavin metabolism
Vitamin B6 metabolism
Nicotinate and nicotinamide metabolism
Pantothenate and CoA biosynthesis
Biotin metabolism
Lipoic acid metabolism
Folate biosynthesis
Terpenoid backbone biosynthesis
Nitrogen metabolism
Sulfur metabolism
Caprolactam degradation
Aminoacyl-tRNA biosynthesis